Predictive value of EGFR mutation in non–small‐cell lung cancer patients treated with platinum doublet postoperative chemotherapy

The mutation status of tumor tissue DNA (n = 389) of resected stage II‐III non‐squamous non–small‐cell lung cancer (Ns‐NSCLC) was analyzed using targeted deep sequencing as an exploratory biomarker study (JIPANG‐TR) for the JIPANG study, a randomized phase III study of pemetrexed/cisplatin (Pem/Cis)...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Toshiaki, Sakai, Kazuko, Kenmotsu, Hirotsugu, Yoh, Kiyotaka, Daga, Haruko, Ohira, Tatsuo, Ueno, Tsuyoshi, Aoki, Tadashi, Hayashi, Hidetoshi, Yamazaki, Koji, Hosomi, Yukio, Chen‐Yoshikawa, Toyofumi F., Okumura, Norihito, Takiguchi, Yuichi, Sekine, Akimasa, Haruki, Tomohiro, Yamamoto, Hiromasa, Sato, Yuki, Akamatsu, Hiroaki, Seto, Takashi, Saeki, Sho, Sugio, Kenji, Nishio, Makoto, Inokawa, Hidetoshi, Yamamoto, Nobuyuki, Nishio, Kazuto, Tsuboi, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748214/
https://www.ncbi.nlm.nih.gov/pubmed/34689382
http://dx.doi.org/10.1111/cas.15171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748214/
https://www.ncbi.nlm.nih.gov/pubmed/34689382
http://dx.doi.org/10.1111/cas.15171

Ejemplares similares